| Financial Year |
March 31 2023 |
| Monetary Funds |
1,716,837,486.73 |
| Held-for-trading Financial Assets |
650,000,000.00 |
| Notes Receivable |
329,886,421.13 |
| Accounts Receivable |
2,685,497,135.22 |
| Advances to Suppliers |
177,331,751.93 |
| Other Receivables |
92,072,026.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,730,211,039.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,018,849.38 |
| Total Current Assets |
8,457,736,909.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
214,505,046.57 |
| Investment Properties |
2,077,936.90 |
| Fixed Assetes |
865,314,766.64 |
| Under-construction Projects |
505,383,221.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
252,474,405.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,719,214.51 |
| Deferred Income Tax Assets |
38,446,635.68 |
| Other Non-Current Assets |
48,493,700.90 |
| Sub-Total of Non-Current Assets |
2,067,663,142.30 |
| Total Assets |
10,525,400,051.52 |
| Short-Term Loans |
302,511,763.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
228,172,464.26 |
| Accounts Payable |
1,184,493,335.25 |
| Accounts Received In Advance |
407,546.02 |
| Employee Compensation Payable |
9,218,014.39 |
| Taxes Payable |
19,663,679.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
263,658,599.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,304,594.01 |
| Other Current Liabilities |
44,743,591.92 |
| Sub-Total of Current Liabilities |
2,168,264,096.92 |
| Long-term Loans |
415,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,100,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
12,221,801.27 |
| Deferred Income Tax Liabilities |
6,294,391.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
560,388,665.79 |
| Total Liabilities |
2,728,652,762.71 |
| Paid-In Capital(Or Share Stock) |
710,629,386.00 |
| Capital Surplus |
3,016,247,582.80 |
| Surplus Reserve |
62,769,700.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,020,543,947.14 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,796,747,288.81 |
| Owner's Equity（Stockholder's Equity） |
7,796,747,288.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,525,400,051.52 |
